Evidence map›Paper›PMID 26403976›Full record

ArticleBMC complementary and alternative medicine2015

Fermented So-Cheong-Ryong-Tang (FCY) induces apoptosis via the activation of caspases and the regulation of MAPK signaling pathways in cancer cells.

Nam-Hui Yim, Aeyung Kim, Young Pil Jung, Taesoo Kim, Choong Je Ma, Jin Yeul Ma

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Isobavachalcone Induces ROS-Mediated ApoptosisOxidative medicine and cellular longevity · 2018
    Article
  8. Article
  9. Article
  10. A Molecular Basis for the Inhibition of Transient Receptor Potential Vanilloid Type 1 by Gomisin A.Evidence-based complementary and alternative medicine : eCAM · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nam-Hui YimKM-Application Center, Korea Institute of Oriental Medicine, 1672, Yuseongdaero, Yuseong, Daejeon, 305-811, Republic of Korea.
Aeyung KimKM-Application Center, Korea Institute of Oriental Medicine, 1672, Yuseongdaero, Yuseong, Daejeon, 305-811, Republic of Korea.
Young Pil JungKM-Application Center, Korea Institute of Oriental Medicine, 1672, Yuseongdaero, Yuseong, Daejeon, 305-811, Republic of Korea.
Taesoo KimKM-Application Center, Korea Institute of Oriental Medicine, 1672, Yuseongdaero, Yuseong, Daejeon, 305-811, Republic of Korea.
Choong Je MaDepartment of Biomaterials Engineering, Division of Bioscience and Biotechnology, Kangwon National University, Chuncheon, 200-701, South Korea.
Jin Yeul MaKM-Application Center, Korea Institute of Oriental Medicine, 1672, Yuseongdaero, Yuseong, Daejeon, 305-811, Republic of Korea. jyma@kiom.re.kr.
Korea Institute of Oriental Medicine · KRKangwon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSo-Cheong-Ryong-Tang (CY), a traditional herbal formula, mainly has been shown to possess allergic rhinitis and asthma for hundreds of years in Asian countries. Although this medicine has been attracted Asian scientists with investigating mechanisms of action against inflammatory-related diseases, there is a little available information on the anti-cancer effect of CY, especially on the fermented form (FCY). In this study, we explored the chemopreventive/chemotherapeutic efficacy of FCY against cancer cells and proved the efficacy of FCY through performing in vivo xenograft assay.

methodsCY was fermented with bacteria and lyophilized. For analysis of the constituents of CY and FCY, high performance liquid chromatography (HPLC)-DAD system was performed. To detect the anti-cancer effect of FCY, cell viability assay, caspase activity assay, cell cycle analysis, and Western blot analysis were performed in AGS human gastric cancer cells. The inhibitory effects of tumor growth by CY and FCY were evaluated in athymic nude mice inoculated with HCT116 human colon cancer cells.

resultsAs a result of analyzing the 11components present in CY and FCY, the contents of ephedrine HCl, glycyrrhizin, gingerol, schisandrin, and gomisin A were respectively increased by fermentation in FCY. The treatment of CY or FCY inhibited the viability of AGS cells, interestingly, the inhibition of cancer cell growth was enhanced by fermentation of CY. FCY induced the apoptosis through activating the caspase-3, -8, and -9. Additionally, FCY regulated the activation of mitogen-activated protein kinases (MAPKs) including extracellular signal-regulated kinase (ERK), p38, and c-Jun NH2-terminal kinase (JNK). In vivo xenografts, administration of FCY significantly inhibited the tumor formation, and improved the anti-tumor effect compared to that of CY in athymic nude mice.

conclusionsFCY indicated significant anti-cancer effects, and its efficacy against tumor formation was improved than that of CY, therefore, FCY might be used for applications of traditional medicine against cancer in modern complementary and alternative therapeutics. Graphical Abstract ᅟ.

Indexed as

AnimalsAntineoplastic AgentsApoptosisCaspasesCell CycleCell Line, TumorCell SurvivalDrugs, Chinese HerbalFemaleFermentationHCT116 CellsHumansMiceMice, NudeMitogen-Activated Protein KinasesSignal TransductionAntineoplastic AgentsCaspasesDrugs, Chinese HerbalMitogen-Activated Protein Kinasessho-seiryu-to

Identifiers

PMID26403976
PMCPMC4582731
OpenAlexW2100983328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.